New Zealand markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
223.32+0.84 (+0.38%)
At close: 04:00PM EST
223.25 -0.07 (-0.03%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
9,835,600
9,835,600
10,173,400
10,981,700
13,444,600
Cost of revenue
2,533,400
2,533,400
2,278,300
2,109,700
1,805,200
Gross profit
7,302,200
7,302,200
7,895,100
8,872,000
11,639,400
Operating expenses
Research development
2,462,000
2,462,000
2,231,100
2,501,200
3,990,900
Selling general and administrative
2,549,700
2,549,700
2,403,600
2,674,300
2,504,500
Total operating expenses
5,471,100
5,471,100
4,993,200
6,064,000
7,193,100
Operating income or loss
1,831,100
1,831,100
2,901,900
2,808,000
4,446,300
Interest expense
246,900
246,900
246,600
253,600
222,500
Total other income/expenses net
-563,900
-563,900
847,200
-820,200
781,700
Income before tax
1,296,800
1,296,800
3,591,800
1,745,200
5,047,500
Income tax expense
135,300
135,300
632,800
52,500
992,300
Income from continuing operations
1,161,500
1,161,500
2,961,600
1,727,600
4,060,500
Net income
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Net income available to common shareholders
1,161,100
1,161,100
3,046,900
1,556,100
4,000,600
Basic EPS
10.14
8.02
20.96
10.44
24.86
Diluted EPS
10.06
7.97
20.87
10.40
24.80
Basic average shares
144,475
144,700
145,300
149,100
160,900
Diluted average shares
145,475
145,600
146,000
149,600
161,300